Trial Profile
The Phase Ⅳ Clinical Trial to Evaluate the Safety, Immunogenicity, and Immune Persistence of Three Consecutive Lots of an Inactivated Hepatitis A Vaccine in Healthy Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine (Healive) (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A
- Focus Pharmacodynamics
- Sponsors Sinovac Biotech
- 24 Apr 2008 Results have been published
- 01 Nov 2007 New trial record.